M. Higgins

发表

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.

K. Kisich, L. Heifets, S. Gelperina, 2007, International journal of pharmaceutics.

Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs.

Benjamin H. Brodsky, M. Cynamon, L. Heifets, 2008, Tuberculosis.

Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis

K. Kisich, G. Diamond, L. Heifets, 2001, Infection and Immunity.

Tumor Necrosis Factor Alpha Stimulates Killing of Mycobacterium tuberculosis by Human Neutrophils

K. Kisich, G. Diamond, L. Heifets, 2002, Infection and Immunity.

Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation.

K. Kisich, S. Winston, R. Sievers, 2011, Vaccine.

Adaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei

M. Voskuil, A. Vázquez-Torres, M. Higgins, 2011, Antimicrobial Agents and Chemotherapy.

Identification of a Mycobacterium tuberculosis Strain with Stable, Low-Level Resistance to Isoniazid

S. Siddiqi, L. Heifets, G. Morlock, 2004, Journal of Clinical Microbiology.

Anti-tuberculosis activity of α-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37.

R. Hodges, M. Voskuil, K. Kisich, 2011, Protein and peptide letters.

Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs.

Benjamin H. Brodsky, M. Cynamon, L. Heifets, 2008, Tuberculosis.